Cannabis in the DMV: How Maryland Stacks Up Against D.C., Virginia, Pennsylvania, and Delaware

A state-by-state look at cannabis in Maryland, D.C., Virginia, Pennsylvania, and Delaware—covering sales, legalization timelines, retail access, and trends.

Cannabis in the DMV: How Maryland Stacks Up Against D.C., Virginia, Pennsylvania, and Delaware

When people talk about “DMV cannabis,” it sounds like one regional market. In reality, Maryland, Washington D.C., Virginia, Pennsylvania, and Delaware all operate under very different systems — with different timelines, sales structures, retail footprints, and revenue models.

Maryland may be our home base, but understanding how the surrounding states compare gives important context to where the market stands today — and where it may head next.

Below is a state-by-state breakdown of legalization timelines, market size, retail footprint, tax revenue, and consumer trends across the region.

Legal Timeline: Who Legalized What — and When?

Maryland

• Medical Cannabis: 2014 (sales began 2017)

• Adult-Use: November 2022, sales began July 1, 2023.

Maryland transitioned from a mature medical program into adult-use retail quickly, allowing existing medical dispensaries to convert to dual-license operations at launch. Roughly 100 licensed dispensaries were operational at the adult-use rollout.

Washington, D.C.

• Medical Cannabis: 1998 (sales began 2013)

• Initiative 71 (possession & home grow) took effect: February 26, 2015, Adult-use sales not permitted due to Congressional restriction

D.C. presents one of the most unique markets in the country. While possession and home grow are legal, Congress has prohibited the District from establishing a regulated adult-use retail system. As a result, D.C.’s industry operates primarily as a medical program, though enforcement and regulatory efforts have evolved in recent years to address unlicensed retail activity.

Virginia

• Medical Cannabis: 2018 (limited program, expanded over time)

• Adult-Use: Possession legalized July 1, 2021; sales not operational.

Virginia allows possession and limited home grow, but has not launched adult-use retail sales. The regulated industry remains medical-only, operated through a vertically integrated pharmaceutical processor model.

Pennsylvania

• Medical Cannabis: Established April 17, 2016

• Adult-use: Not legalized

Pennsylvania maintains one of the largest medical-only markets in the country. While adult-use legislation has been debated, it remains a medical program as of 2026.

Delaware

• Medical Cannabis: July 1, 2011

• Adult-Use: Legalized 2023, sales began August 1, 2025

Delaware is the newest adult-use entrant in the region, launching retail sales in mid-2025 through a conversion model that allowed existing medical operators to begin recreational sales first.

Market Size & Consumer Spending

Comparing total market size can be complex because some states report taxable sales while others report total program revenue. Still, clear differences emerge.

Maryland

In the calendar year 2025, Maryland brought in over 1.17 billion dollars in cannabis sales.

Maryland’s cannabis tax rate increased to 12% in mid-2025, and quarterly collections since then continue to reflect strong market performance.

Because medical sales are not subject to the adult-use excise tax, total statewide cannabis spending exceeds the adult-use taxable figure.

Washington, D.C.

D.C. publishes monthly medical cannabis sales reports. In January 2026 alone, total medical cannabis sales exceeded $8.7 million, with D.C. resident sales accounting for roughly $3.5 million of that total.

Without adult-use retail, D.C.’s regulated sales volume remains significantly smaller than Maryland’s.

Pennsylvania

Pennsylvania’s medical program has generated approximately $8.5 billion in cumulative sales since the program’s inception.

While Pennsylvania lacks adult-use retail, its large population and early medical adoption make it one of the largest medical-only markets in the United States.

Virginia

Virginia’s reporting focuses more heavily on program participation and facility counts rather than total retail sales in public-facing annual summaries. As a medical-only market with a limited number of operators, it has a considerably smaller total sales volume than Maryland or Pennsylvania.

Delaware

Delaware’s adult-use market launched on August 1, 2025. During its first weekend alone, the state recorded approximately $625,000 in sales, generating $93,750 in tax revenue under its 15% retail marijuana tax.

As the newest adult-use state in the region, Delaware’s long-term market size remains to be seen.

Retail Footprint: How Many Dispensaries?

Retail access varies dramatically across the DMV.

Maryland

• Approximately 100+ licensed dispensaries

• Dual medical/adult-use operators statewide

Maryland currently offers the most robust retail access in the immediate DMV region.

Washington, D.C.

DC has approximately 60 licensed medical cannabis dispensaries. This number follows a large initiative to crack down on illicit “gifting” stores. 

Virginia

• 19 dispensing facilities

• Operated under vertically integrated pharmaceutical processors

Virginia’s footprint is intentionally limited compared to neighboring states.

Pennsylvania

• 185 operational dispensaries

• 30 grower/processors

Pennsylvania’s retail network is extensive, especially for a medical-only state.

Delaware

• 12 dispensaries converted from medical to adult-use at launch

Retail access is currently limited but expected to expand as additional licenses are issued.

State Revenue: What Cannabis Generates for Each State

Tax structure is one of the clearest differentiators among the markets.

Maryland

• 9% adult-use tax in 2024 (increased to 12% mid-2025)

• $72.9M collected in adult-use cannabis tax revenue in 2024

Maryland directs cannabis tax revenue toward community reinvestment, public health, and state priorities.

Delaware

• 15% retail marijuana tax

• First weekend revenue: $93,750

Delaware’s tax rate is currently higher than Maryland’s initial adult-use rate.

D.C., Virginia, Pennsylvania

• D.C. generates tax revenue from medical sales only

• Virginia’s revenue reflects medical program operations

• Pennsylvania’s revenue stems from medical sales taxes and fees

Without adult-use programs (or, in D.C.’s case, adult-use retail), revenue totals remain structurally limited compared to Maryland's.

What Are People Buying?

Only some states publicly publish product-category breakdowns.

Washington, D.C. (January 2026 Medical Sales by Category)

• Flower/Bud: ~$3.08M

• Vape cartridges: ~$1.02M

• Infused edibles: ~$678K

Flower continues to lead sales volume, with vapes and edibles following — consistent with national trends.

Maryland

While detailed category breakdowns are not always consolidated into one public monthly report, retail trends across dispensaries show similar patterns:

• Flower remains foundational

• Vape products and concentrates maintain strong demand

• Edibles continue to grow in consumer adoption

Pennsylvania & Virginia

As medical-only markets, product offerings tend to emphasize regulated formats, including:

• Vaporization products

• Tinctures

• Capsules

• Flower (where permitted)

Delaware

As a newly launched adult-use state, early demand has reflected strong interest in traditional retail formats, though longer-term consumption trends are still developing.

Key Differences Across the Region

 

Same Region — Very Different Realities

Despite geographic proximity, the cannabis industry in the DMV is far from uniform.

• Maryland operates a full adult-use retail system with significant tax revenue and broad retail access.

• D.C. remains restricted by federal oversight, creating a uniquely structured market.

• Virginia has legalized possession but not retail.

• Pennsylvania maintains one of the largest medical-only markets in the country.

• Delaware is the region’s newest adult-use state, just beginning to scale.

For businesses, operators, and consumers alike, these differences shape everything — from product availability and pricing to tax structure and regulatory oversight.

Understanding these contrasts highlights just how quickly the cannabis landscape is evolving — not just nationally, but right here in our own backyard.